Hepion Pharmaceuticals, Inc. (HEPA) stock
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Earnings
Hepion Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Hepion Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Hepion Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Hepion Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Hepion Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- Update
- Update
- News
- News
- Update
- Update
- Update
- News
- News
- Update
- Update
See a number that looks wrong?